ORIFARM GENERICS HOLDING A/S: Financial statements 2012
CVR: 27347223
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
ORIFARM GENERICS HOLDING A/S (CVR 27347223) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 13,109,000 and a net result of DKK 7,089,000. Equity in the 2012 report amounted to DKK 11,989,000. The solvency ratio was 31%.
- Gross Profit
- DKK 13,109,000
- Profit/Loss
- DKK 7,089,000
- Equity
- DKK 11,989,000
- Total Assets
- DKK 38,689,000
Official annual report
Keep an eye on ORIFARM GENERICS HOLDING A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout ORIFARM GENERICS HOLDING A/S
ORIFARM GENERICS HOLDING A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named COPYFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Birgitte Bøgh-Sørensen, Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 0 employees (2016). In 2025, the company reported revenue of DKK 459,463,000 and a net result of DKK 273,125,000 compared with DKK 89,363,000 the year before. Equity in the 2025 report amounted to DKK 2,399,752,000.